Joseph E. Schwartz, Ph.D.
- Assistant Professor, Division of General Medicine
- Ph.D., Sociology (1978), Harvard University, Cambridge, MA
- M.A., Sociology (1977), Harvard University, Cambridge, MA
- Visiting student, Sociology (1975), Oxford University, Oxford, England
- B.A., Mathematics, Sociology (1972), Cornell University, Ithaca, NY
Dr. Joseph Schwartz is an internationally recognized leader in the fields of cardiovascular behavioral medicine and quantitative methodology. He is an elected Fellow of the Society of Behavioral Medicine and the Academy of Behavioral Medicine Research, a member of the American Psychosomatic Society, American Society of Hypertension, and MacArthur Research Network on Socioeconomic Status and Health. He has been the Principal Investigator (PI) or Project Leader of numerous federally-funded research grants and co-investigator, biostatistician or statistical consultant on many more. Currently, he is the PI of a program project (Psychosocial Factors and Cardiovascular Disease) and an R01 (Physical Activity, Depression, and Post-ACS Survival). Within the program project, he has led the Work Site Blood Pressure Study from 1991-2003 (59 publications in peer-reviewed journals) and has led the ongoing Masked Hypertension Study since its inception in 2003. He has also led the Data Management and Statistics Core since 1991. His areas of statistical expertise include multilevel models for continuous and binary data (especially intensive repeated measures data), structural equation models, survival analysis, the impact of measurement and misclassification errors on statistical analyses, and receiver operating characteristic (ROC) curve analysis. He has considerable experience conducting and analyzing data from randomized controlled trials. He currently serves on the Data Safety Monitoring Board for a smoking cessation RCT, and he is the biostatistician for two recently completed RCTs. Also, in collaboration with others, he has contributed to the collection and analysis of data pertaining to quality of life and depressive symptoms among patients with heart failure and other cardiovascular disease. He is also the PI of an R01 that involves the collection of 3-months of actigraphy data in a cohort of patients with acute coronary syndromes, and he has extensive experience analyzing 24-hour continuously ascertained data. He has successfully mentored many junior faculty members, including the K23 awards of Dr. Karina Davidson and 5 other early career researchers.
- Gerin W, Tobin JN, Schwartz JE, Chaplin W, Rieckmann N, Davidson KW, Goyal TM, Jhalani J, Cassells A, Feliz K, Khalida C, Diaz-Gloster M, Ogedegbe G. The medication adherence and blood pressure control (ABC) trial: A multisite randomized controlled trial in a hypertensive, multi-cultural, economically disadvantaged population. Contemp Clin Trials, 28(2007): 459-471. PMID: 17287150.
- Davidson KW, Burg MM, Kronish IM, Shimbo D, Dettenborn L, Mehran R, Vorchheimer D, Clemow L, Schwartz JE, Lespérance F, and Rieckmann N. Association of anhedonia with recurrent major adverse cardiac events and mortality 1 year after acute coronary syndrome. Arch Gen Psych, 67(2010): 480-488. PMCID: PMC3058237.
- Davidson KW, Rieckmann N, Clemow L, Schwartz JE, Shimbo D, Medina V, Albanese G, Kronish I, Hegel M, Burg MM. Enhanced depression care for patients with acute coronary syndrome and persistent depressive symptoms: Coronary Psychosocial Evaluation Studies randomized controlled trial. Arch Int Med, 170(2010): 600-608. PMCID: PMC2882253.
- Freedland KE, Mohr DC, Davidson KW, Schwartz JE. Usual and unusual care: Existing practice control groups in randomized controlled trials of behavioral interventions. Psychosom Med, 73(2011): 323-335.
- Shaffer JA, Whang W, Shimbo D, Burg M, Schwartz JE, Davidson KW. Do different depression phenotypes have different risks for recurrent coronary heart disease? Health Psychol Rev, 2011: 1-15, iFirst Article.